President signs health legislation to combat Alzheimer's disease at close of 115th Congress
Upcoming Events
Related News
Key Takeaways
On December 31, President Trump signed into law the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act (H.R. 4256/S. 2076), a bipartisan bill aimed at the prevention and treatment of Alzheimer’s disease. The NACo-supported bill authorizes $20 million annually for FY 2020 through FY 2024 to promote brain health activities under the Centers for Disease Control and Prevention’s (CDC) Alzheimer’s Disease and Healthy Aging Program.
Once enacted, the legislation will create a nationwide public health infrastructure program to implement risk-reduction measures around Alzheimer’s disease. As part of this effort, the bill directs the CDC to establish Alzheimer’s Centers of Excellence at eligible organizations to increase awareness among health care professionals and assist public health departments implementing evidence-based practices that increase early detection and support care-planning for residents living with the disease.
Additionally, the Centers will be able to award cooperative agreement grants to public health departments and nonprofit organizations to improve program quality and data-reporting on Alzheimer’s. County health departments will be eligible to apply for these grants.
NACo supports increased federal resources for the prevention, treatment and care for individuals with Alzheimer’s, and signed letters of support for this bill to the U.S. House of Representatives and U.S. Senate. County leaders will continue to engage with congressional legislators to ensure counties have the resources to support the health and well-being of residents.
---
Click here to view the letter to the U.S. House of Representatives.
Click here to view the letter to the U.S. Senate.
Click here to view NACo’s 2019 legislative priorities.
Attachments
Related News
CMS announces new funding opportunity for the Innovation in Behavioral Health Model
On October 16, the Centers for Medicare & Medicaid Services (CMS) released a Notice of Funding Opportunity (NOFO) for Cohort II of the Innovation in Behavioral Health (IBH) Model. This new round of funding builds on the initial IBH model announced in 2024 and continues CMS’s efforts to improve outcomes for individuals with moderate to severe mental health conditions and substance use disorders (SUDs) by advancing integration between behavioral and physical healthcare.
Michelle Alyssa Go Act reintroduced in the 119th Congress, a critical step for county behavioral health systems
On September 18, the Michelle Alyssa Go Act was reintroduced in the U.S. House of Representatives. This bipartisan legislation aims to increase the number of federal Medicaid-eligible in-patient psychiatric beds from 16 to 36, providing critical support for individuals seeking treatment for mental health and substance use disorders.
Congress passes SUPPORT Act reauthorization
On September 18, the U.S. Senate passed the SUPPORT for Patients and Communities Reauthorization Act of 2025 (SUPPORT Act Reauthorization) (H.R. 2483) by voice vote, following House passage earlier this year. With strong bipartisan backing in both chambers, the legislation now heads to the President’s desk for signature.